Skip to main content

Table 4 Distribution of antibiotics prescribed based on indications

From: Antibiotic use among hospitalized patients in northern Nigeria: a multicenter point-prevalence survey

Antibiotic

CI

HI

SP3

MP

UI

Ciprofloxacin

29 (16.7)

8 (11.0)

7 (6.9)

4 (6.0)

7 (20.6)

Levofloxacin

4 (2.3)

0 (0.0)

1 (1.0)

1 (1.5)

0 (0.0)

Ceftriaxone

21 (12.1)

6 (8.2)

8 (7.9)

13 (19.4)

6 (17.6)

Cefuroxime

6 (3.4)

2 (2.7)

9 (8.9)

0 (0.0)

0 (0.0)

Cefixime

4 (2.3)

4 (5.5)

13 (12.9)

0 (0.0)

1 (2.9)

Ceftazidime

1 (0.6)

5 (6.8)

0 (0.0)

3 (4.5)

0 (0.0)

Metronidazole

41 (23.6)

15 (20.5)

21 (20.8)

11 (16.4)

11 (32.4)

Tinidazole

5 (2.9)

7 (9.6)

13 (12.9)

2 (3.0)

1 (2.9)

Secnidazole

0 (0.0)

1 (1.4)

0 (0.0)

0 (0.0)

0 (0.0)

Ampicillin-sulbactam

2 (1.1)

3 (4.1)

0 (0.0)

1 (1.5)

1 (2.9)

Amoxicillin-clavulanate

16 (9.2)

5 (6.8)

11 (10.9)

6 (9.0)

2 (5.9)

Amoxicillin

6 (3.4)

2 (2.7)

8 (7.9)

1 (1.5)

1 (2.9)

Ampicillin-cloxacillin

1 (0.6)

1 (1.4)

0 (0.0)

8 (11.9)

1 (2.9)

Ampicillin-floxacillin

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (2.9)

Crystalline penicillin

4 (2.3)

1 (1.4)

0 (0.0)

3 (4.5)

0 (0.0)

Erythromycin

1 (0.6)

0 (0.0)

1 (1.0)

0 (0.0)

0 (0.0)

Azithromycin

5 (2.9)

0 (0.0)

0 (0.0)

1 (1.5)

0 (0.0)

Cotrimoxazole

2 (1.1)

1 (1.4)

0 (0.0)

1 (1.5)

0 (0.0)

Doxycycline

1 (0.6)

0 (0.0)

2 (2.0)

0 (0.0)

1 (2.9)

Chloramphenicol

3 (1.7)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Gentamicin

13 (7.5)

10 (13.7)

4 (4.0)

10 (14.9)

1 (2.9)

Clindamycin

9 (5.2)

1 (1.4)

3 (3.0)

1 (1.5)

0 (0.0)

Meropenem

0 (0.0)

1 (1.4)

0 (0.0)

0 (0.0)

0 (0.0)

Nitrofurantoin

0 (0.0)

0 (0.0)

0 (0.0)

1 (1.5)

0 (0.0)

  1. CI Community acquired infections, HI Hospital acquired infections, SP Surgical prophylaxis, MP Medical prophylaxis and UI Unknown indication